{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:31:55Z","timestamp":1769124715020,"version":"3.49.0"},"reference-count":93,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Aortic stenosis (AS) is a very common valve disease and is associated with high mortality once it becomes symptomatic. Arterial hypertension (HT) has a high prevalence among patients with AS leading to worse left ventricle remodeling and faster degeneration of the valve. HT also interferes with the assessment of the severity of AS, leading to an underestimation of the real degree of stenosis. Treatment of HT in AS has not historically been pursued due to the fear of excess reduction in afterload without a possibility of increasing stroke volume due to the fixed aortic valve, but most recent evidence shows that several drugs are safe and effective in reducing BP in patients with HT and AS. RAAS inhibitors and beta-blockers provide benefit in selected populations based on their profile of pharmacokinetics and pharmacodynamics. Different drugs, on the other hand, have proved to be unsafe, such as calcium channel blockers, or simply not easy enough to handle to be recommended in clinical practice, such as PDE5i, MRA or sodium nitroprusside. The present review highlights all available studies on HT and AS to guide antihypertensive treatment.<\/jats:p>","DOI":"10.3390\/jcm10235553","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T01:43:22Z","timestamp":1638323002000},"page":"5553","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Arterial Hypertension in Aortic Valve Stenosis: A Critical Update"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-3058","authenticated-orcid":false,"given":"Christian","family":"Basile","sequence":"first","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Fucile","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lembo","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1979-7131","authenticated-orcid":false,"given":"Maria Virginia","family":"Manzi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Ilardi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Franzone","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-1408","authenticated-orcid":false,"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Science, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., de Bonis, M., and de Paulis, R. (2021). 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J., ehab395.","DOI":"10.1093\/ejcts\/ezac209"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ehjci\/jew013","article-title":"Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: Results from the PROGRESSA study","volume":"18","author":"Tastet","year":"2016","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/hrt.2003.030601","article-title":"Impact of systemic hypertension on the assessment of aortic stenosis","volume":"91","author":"Kadem","year":"2005","journal-title":"Heart"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ehjcvp\/pvaa040","article-title":"Management of patients with combined arterial hypertension and aortic valve stenosis: A consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"7","author":"Mancusi","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e009675","DOI":"10.1161\/CIRCIMAGING.119.009675","article-title":"Long-term risk factors for dilatation of the proximal aorta in a large cohort of children with bicuspid aortic valve","volume":"13","author":"Blais","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e009717","DOI":"10.1161\/CIRCIMAGING.119.009717","article-title":"Redictors of bicuspid aortic valve-associated aortopathy in childhood: A report from the MIBAVA Consortium","volume":"13","author":"Grattan","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular health study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1093\/eurheartj\/ehy486","article-title":"Elevated blood pressure and risk of aortic valve disease: A cohort analysis of 5.4 million UK adults","volume":"39","author":"Rahimi","year":"2018","journal-title":"Eur. Heart. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/08037050701343241","article-title":"Severe aortic stenosis and its association with hypertension: Analysis of clinical and echocardiographic parameters","volume":"16","author":"Linhartova","year":"2007","journal-title":"Blood Press."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: A population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/oxfordjournals.eurheartj.a060602","article-title":"Factors associated with calcific aortic valve degeneration in the elderly","volume":"15","author":"Lindroos","year":"1994","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.jacc.2005.12.070","article-title":"Development of mild aortic valve stenosis in a rabbit model of hypertension","volume":"47","author":"Cuniberti","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(03)00284-3","article-title":"Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis","volume":"170","author":"Kaden","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0735-1097(01)01705-3","article-title":"Progression of human aortic valve stenosis is associated with tenascin-C expression","volume":"39","author":"Satta","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","first-page":"377","article-title":"Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II","volume":"141","author":"Mackie","year":"1992","journal-title":"Am. J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","article-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance?","volume":"44","author":"Touyz","year":"2004","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.107.156745","article-title":"Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification","volume":"28","author":"Liberman","year":"2008","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"Shavelle","year":"2002","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehi706","article-title":"Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves","volume":"27","author":"Helske","year":"2006","journal-title":"Eur. Hear. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.niox.2006.10.003","article-title":"Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA)","volume":"16","author":"Ngo","year":"2007","journal-title":"Nitric Oxide"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1524-6175.2004.03272.x","article-title":"Aortic calcification is associated with age and sex but not left ventricular mass in essential hypertension","volume":"6","author":"Tsakiris","year":"2004","journal-title":"J. Clin. Hypertens."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2004.07.054","article-title":"Induction of local angiotensin II-producing systems in stenotic aortic valves","volume":"44","author":"Helske","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.HYP.0000070029.30058.59","article-title":"Symptomatic aortic stenosis: Does systemic hypertension play an additional role?","volume":"41","author":"Huang","year":"2003","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.amjcard.2021.03.036","article-title":"Prevalence of left ventricular hypertrophy caused by systemic hypertension preceding the development of severe aortic stenosis","volume":"150","author":"Aldrugh","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/HJH.0000000000001717","article-title":"Three-dimensional echocardiographic ventricular mass\/end-diastolic volume ratio in native hypertensive patients: Relation between stroke volume and geometry","volume":"36","author":"Lembo","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.112.194878","article-title":"Hypertension in aortic stenosis: Implications for left ventricular structure and cardiovascular events","volume":"60","author":"Rieck","year":"2012","journal-title":"Hypertension"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2004.10.081","article-title":"Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: Implications for diagnosis and treatment","volume":"46","author":"Briand","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/hrt.2006.111914","article-title":"Assessment of aortic stenosis severity: Check the valve but don\u2019t forget the arteries!","volume":"93","author":"Pibarot","year":"2007","journal-title":"Heart"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/CIRCULATIONAHA.113.003071","article-title":"Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction","volume":"128","author":"Eleid","year":"2013","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1540-8175.2011.01419.x","article-title":"Global longitudinal strain in relation to the severity of aortic stenosis: A two-dimensional speckle-tracking study","volume":"28","author":"Miyazaki","year":"2011","journal-title":"Echocardiography"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/jocs.13183","article-title":"Heterogeneity of systolic dysfunction in patients with severe aortic stenosis and preserved ejection fraction","volume":"32","author":"Lindman","year":"2017","journal-title":"J. Card. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/HJH.0000000000001963","article-title":"The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction","volume":"37","author":"Tadic","year":"2019","journal-title":"J. Hypertens."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/ehjci\/jex189","article-title":"Left ventricular global longitudinal strain is predictive of all-cause mortality independent of aortic stenosis severity and ejection fraction","volume":"19","author":"Ng","year":"2018","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.amjcard.2017.05.032","article-title":"Role of global longitudinal strain in the prediction of outcome in patients with severe aortic valve stenosis","volume":"120","author":"Fries","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/CIRCIMAGING.114.002041","article-title":"Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction","volume":"7","author":"Kusunose","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2018.03.359","article-title":"Novel echocardiographic parameters in patients with aortic stenosis and preserved left ventricular systolic function undergoing surgical aortic valve replacement","volume":"122","author":"Huded","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_38","unstructured":"Liga, R., Gimelli, A., De Carlo, M., Marzullo, P., Pedrinelli, R., and Petronio, A.S. (2020). Cardiac sympathetic dysfunction in left ventricular hypertrophy caused by arterial hypertension and degenerative aortic stenosis. J. Nucl. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/HJH.0000000000002149","article-title":"Hypertension in aortic stenosis: Relationship with revealed symptoms and functional measures on treadmill exercise","volume":"37","author":"Saeed","year":"2019","journal-title":"J. Hypertens."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e010735","DOI":"10.1161\/JAHA.118.010735","article-title":"Exercise treadmill testing in moderate or severe aortic stenosis: The left ventricular correlates of an exaggerated blood pressure rise","volume":"7","author":"Saeed","year":"2018","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/hrt.2009.181644","article-title":"Treadmill exercise in apparently asymptomatic patients with moderate or severe aortic stenosis: Relationship between cardiac index and revealed symptoms","volume":"96","author":"Rajani","year":"2010","journal-title":"Heart"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e000950","DOI":"10.1136\/openhrt-2018-000950","article-title":"Rapid early rise in heart rate on treadmill exercise in patients with asymptomatic moderate or severe aortic stenosis: A new prognostic marker?","volume":"6","author":"Chambers","year":"2019","journal-title":"Open Heart"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ejechocard\/jer044","article-title":"Valvuloarterial impedance in aortic stenosis: Look at the load, but do not forget the flow","volume":"12","author":"Lancellotti","year":"2011","journal-title":"Eur. J. Echocardiogr."},{"key":"ref_44","first-page":"277","article-title":"Can high blood pressure mask severe aortic stenosis?","volume":"8","author":"Chambers","year":"1999","journal-title":"J. Heart Valve Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"40B","DOI":"10.1016\/S0828-282X(07)71009-7","article-title":"New concepts in valvular hemodynamics: Implications for diagnosis and treatment of aortic stenosis","volume":"23","author":"Pibarot","year":"2007","journal-title":"Can. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jcmg.2008.12.021","article-title":"Low-flow aortic stenosis in asymptomatic patients: Valvular\u2013arterial impedance and systolic function from the SEAS substudy","volume":"2","author":"Cramariuc","year":"2009","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2009.04.079","article-title":"Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis","volume":"54","author":"Hachicha","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jocs.13190","article-title":"The impact of global left ventricular afterload on left ventricular reverse remodeling after aortic valve replacement","volume":"32","author":"Ito","year":"2017","journal-title":"J. Card. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.jacc.2006.03.002","article-title":"Valvular aortic stenosis: Disease severity and timing of intervention","volume":"47","author":"Otto","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/hrt.2006.098392","article-title":"Impact of blood pressure on the Doppler echocardiographic assessment of severity of aortic stenosis","volume":"93","author":"Little","year":"2006","journal-title":"Heart"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jacc.2011.11.078","article-title":"Improving assessment of aortic stenosis","volume":"60","author":"Pibarot","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.115.021213","article-title":"Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: The simvastatin ezetimibe in aortic stenosis study (SEAS)","volume":"134","author":"Nielsen","year":"2016","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jacc.2011.01.063","article-title":"Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis","volume":"58","author":"Nadir","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e036960","DOI":"10.1136\/bmjopen-2020-036960","article-title":"Antihypertensive therapies in moderate or severe aortic stenosis: A systematic review and meta-analysis","volume":"10","author":"Sen","year":"2020","journal-title":"BMJ Open"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ahj.2003.10.017","article-title":"Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic cardiac obstruction\u2013pilot study of enalapril in aortic stenosis (SCOPE-AS)","volume":"147","author":"Chockalingam","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/M13-1505","article-title":"Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: A cohort study","volume":"161","author":"Goel","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.amjcard.2017.11.013","article-title":"Relation between renin-angiotensin system blockers and survival following isolated aortic valve replacement for aortic stenosis","volume":"121","author":"Magne","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2018.18077","article-title":"Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement","volume":"320","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/heartjnl-2017-311738","article-title":"Renin\u2013angiotensin system blockade therapy after transcatheter aortic valve implantation","volume":"104","author":"Ochiai","year":"2017","journal-title":"Heart"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacc.2019.05.055","article-title":"Renin-angiotensin system inhibition following transcatheter aortic valve replacement","volume":"74","author":"Regueiro","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MOL.0b013e3282a66099","article-title":"Aortic valve stenosis: An active atheroinflammatory process","volume":"18","author":"Helske","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2362.2011.02522.x","article-title":"Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves","volume":"41","author":"Couture","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/eci.12169","article-title":"Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis","volume":"43","author":"Capoulade","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1253\/circj.CJ-15-0499","article-title":"Risk factors for progression of degenerative aortic valve disease in the Japanese\u2014The Japanese aortic stenosis study (JASS) prospective analysis","volume":"79","author":"Yamamoto","year":"2015","journal-title":"Circ. J."},{"key":"ref_65","first-page":"337","article-title":"The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality","volume":"21","author":"Ardehali","year":"2012","journal-title":"J. Heart Valve Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.RES.0000205761.22353.5f","article-title":"Angiotensin-converting enzyme ii in the heart and the kidney","volume":"98","author":"Danilczyk","year":"2006","journal-title":"Circ. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ahj.2013.11.002","article-title":"Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: A placebo-controlled, randomized study","volume":"167","author":"Dalsgaard","year":"2014","journal-title":"Am. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijcard.2014.06.013","article-title":"Renin\u2013angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis","volume":"175","author":"Bang","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ehjci\/jev043","article-title":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor ramipril in aortic stenosis (RIAS trial)","volume":"16","author":"Bull","year":"2015","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/FJC.0000000000000182","article-title":"Is blockade of the renin-angiotensin system able to reverse the structural and functional remodeling of the left ventricle in severe aortic stenosis?","volume":"65","author":"Laine","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archinte.165.8.858","article-title":"Angiotensin-converting enzyme inhibitors and change in aortic valve calcium","volume":"165","author":"Probstfield","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00380-010-0052-x","article-title":"Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients","volume":"26","author":"Wakabayashi","year":"2011","journal-title":"Heart Vessel."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/hc4301.098252","article-title":"Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure","volume":"104","author":"Witherow","year":"2001","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/01.CIR.0000017433.90061.2E","article-title":"Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism","volume":"105","author":"Nikolaidis","year":"2002","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bbrc.2007.01.088","article-title":"Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site","volume":"354","author":"Yamamoto","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.0000096609.73772.C5","article-title":"Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin\u2013angiotensin system","volume":"109","author":"Levy","year":"2004","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e006557","DOI":"10.1161\/CIRCIMAGING.117.006557","article-title":"Metoprolol reduces hemodynamic and metabolic overload in asymptomatic aortic valve stenosis patients: A randomized trial","volume":"10","author":"Hansson","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2015.04.083","article-title":"Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis","volume":"190","author":"Rossi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Bang, C.N., Greve, A.M., Rosseb\u00f8, A.B., Ray, S., Egstrup, K., Boman, K., Nienaber, C., Okin, P.M., Devereux, R.B., and Wachtell, K. (2017). Antihypertensive treatment with \u03b2-blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events. J. Am. Heart Assoc., 6.","DOI":"10.1161\/JAHA.117.006709"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jcin.2013.06.012","article-title":"Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis","volume":"6","author":"Dumonteil","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.annemergmed.2015.03.027","article-title":"Complications associated with nitrate use in patients presenting with acute pulmonary edema and concomitant moderate or severe aortic stenosis","volume":"66","author":"Claveau","year":"2015","journal-title":"Ann. Emerg. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa022021","article-title":"Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis","volume":"348","author":"Khot","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ahj.2008.03.012","article-title":"A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis","volume":"156","author":"Stewart","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.127.5.1647","article-title":"Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: Combined administration with inhaled nitric oxide","volume":"127","author":"Lepore","year":"2005","journal-title":"Chest"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.111.081125","article-title":"Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis","volume":"125","author":"Lindman","year":"2012","journal-title":"Circulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","article-title":"Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical","volume":"39","author":"Bermejo","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2019.09.007","article-title":"Antihypertensive treatment with calcium channel blockers in patients with moderate or severe aortic stenosis: Relationship with all-cause mortality","volume":"298","author":"Saeed","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Sutanto, H., Dobrev, D., and Heijman, J. (2021). Angiotensin receptor-neprilysin inhibitor (ARNI) and cardiac arrhythmias. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168994"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10557-020-06995-x","article-title":"Protection of sacubitril\/valsartan against pathological cardiac remodeling by inhibiting the NLRP3 inflammasome after relief of pressure overload in mice","volume":"34","author":"Li","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/jama.2019.12843","article-title":"Effect of sacubitril-valsartan vs. enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: A randomized clinical trial","volume":"322","author":"Desai","year":"2019","journal-title":"JAMA"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Amat-Santos, I.J., S\u00e1nchez-Luna, J.P., Abu-Assi, E., Viu, M.M., Cruz-Gonzalez, I., Nombela-Franco, L., Garc\u00eda, A.J.M., Blas, S.G., Hernandez, J.M.T., and Romaguera, R. (2021). Rationale and design of the dapagliflozin after transcatheter aortic valve implantation (DapaTAVI) randomized trial. Eur. J. Heart Fail.","DOI":"10.1002\/ejhf.2370"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/23\/5553\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:18Z","timestamp":1760168178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/23\/5553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":93,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["jcm10235553"],"URL":"https:\/\/doi.org\/10.3390\/jcm10235553","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}